# AET05 variant 1 is produced correctly

    Code
      res
    Output
                                                Placebo          Xanomeline High Dose   Xanomeline Low Dose
                                                 (N=86)                 (N=84)                (N=84)       
      —————————————————————————————————————————————————————————————————————————————————————————————————————
      Total patient-years at risk                 -1.1                   16.7                  -3.4        
      Number of adverse events observed            31                     40                    45         
      AE rate per 100 patient-years             -2702.33                239.39               -1326.57      
      95% CI                              (-3653.60, -1751.05)     (165.20, 313.58)     (-1714.16, -938.98)

# AET05 variant 2 is produced correctly

    Code
      res
    Output
                                                Placebo          Xanomeline High Dose   Xanomeline Low Dose
                                                 (N=86)                 (N=84)                (N=84)       
      —————————————————————————————————————————————————————————————————————————————————————————————————————
      Total patient-years at risk                 -1.1                   16.7                  -3.4        
      Number of adverse events observed            31                     40                    45         
      AE rate per 100 patient-years             -2702.33                239.39               -1326.57      
      95% CI                              (-1836.10, -3835.74)     (171.02, 325.98)     (-967.61, -1775.06)

